ERBB2 and neoplasm: For instance, doxorubicin-encapsulated exosomes showed efficient targeting to HER2+ and αv integrin-positive breast cancer cells in vitro, and in an in vivo mice model, injected targeted exosomes delivered doxorubicin specifically to tumor tissues inhibiting tumor growth [127].